Biologics

The Center for Orthopedic Care in Fulton, N.Y., began offering a regenerative orthopedic treatment.

Surgeons at Yale Medicine in New Haven, Conn., are using stem cell treatments to treat some hip conditions without joint replacements, ABC affiliate WTNH reported March 1.

Campbell Medical Clinic in Houston added the stromal vascular fraction procedure, according to a Feb. 28 news release.

From product launches to research initiatives, here are six key updates since Jan. 1 to know in the regenerative medicine industry:

A Rhode Island man designed a first-of-its-kind spinal implant made from human bone tissue, NBC affiliate WJAR reported Feb. 23.

Orthofix's Opus BA bioactive strip was fully launched for cervical and lumbar spinal fusion, the devicemaker said Feb. 22.

Theradaptive's OsteoAdapt SP spinal implant received FDA breakthrough designation for posterolateral spinal fusion.

Ortho Regenerative Technologies has initiated a $3 million non-brokered private placement deal, the orthopedic biotechnology company said Feb. 11.

The global orthobiologics market is expected to grow to nearly $8 billion by 2016, according to projections from Transparency Market Research.

Sean McMillan, DO, became the first surgeon to use the Bear anterior cruciate ligament implant in New Jersey, ROI-NJ reported Feb. 3.